One year after the first human case of SARS-CoV-2, two nanomedicine-based mRNA
vaccines have been fast-tracked, developed, and have received emergency use …

Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …

The liposome is the first nanomedicine transformed into the market and applied to human
patients. Since then, such phospholipid bilayer vesicles have undergone technological …

The world is grappling with an unprecedented public health crisis COVID-19 pandemic
caused by the novel coronavirus SARS-CoV-2. Due to the high transmission/mortality rates …

Strong infectivity enables coronavirus disease 2019 (COVID-19) to rage throughout the
world. Moreover, the lack of drugs with definite therapeutic effects further aggravates the …

Severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2)‐induced COVID‐19 is a
complicated disease. Clinicians are continuously facing difficulties to treat infected patients …

Severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) is a highly pathogenic and
transmissible virus. Infection caused by SARS-CoV-2 known as Coronavirus disease 2019 …

Gene therapy has shown great potential to treat various diseases by repairing the abnormal
gene function. However, a great challenge in bringing the nucleic acid formulations to the …

Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a particular
coronavirus strain responsible for the coronavirus disease 2019 (COVID-19), accounting for …

ABSTRACT SARS-CoV-2 firstly emerged in China and sporadically transmitted worldwide.
In March 2020, WHO announced that the infection was a pandemic. The outbreak and rapid …